Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BECTON, DICKINSON AND COMPANY

(BDX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/17/2021 06/18/2021 06/21/2021 06/22/2021 06/23/2021 Date
240.25(c) 240.54(c) 240.83(c) 240.32(c) 240.22(c) Last
1 667 905 2 561 604 1 563 540 1 429 997 1 396 275 Volume
-0.01% +0.12% +0.12% -0.21% -0.04% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 19 455 M - -
Net income 2021 2 308 M - -
Net Debt 2021 13 630 M - -
P/E ratio 2021 30,0x
Yield 2021 1,54%
Sales 2022 19 282 M - -
Net income 2022 2 498 M - -
Net Debt 2022 11 711 M - -
P/E ratio 2022 26,1x
Yield 2022 1,61%
Capitalization 69 860 M 69 860 M -
EV / Sales 2021 4,29x
EV / Sales 2022 4,23x
Nbr of Employees 72 000
Free-Float 79,2%
More Financials
Company
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a... 
More about the company
Ratings of Becton, Dickinson and Company
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about BECTON, DICKINSON AND COMPANY
07:25aBECTON DICKINSON ANDá : Receives US FDA Regulatory Clearance for its Updated Cat..
MT
06:56aBECTON DICKINSON ANDá : BD Announces Expanded 510(k) Clearance for At-Home Syste..
PR
06/22BECTON DICKINSON ANDá : BD Highlights Five-Year ESG Achievements in 2020 Sustain..
PR
06/18Correction to Becton Dickinson Outlook Article on Feb. 6, 2020
DJ
06/14TELEPHARMA DISCONNECT : Federal Circuit Reverses PTAB On Obviousness
AQ
06/14BECTON DICKINSON ANDá : USA Swimming Partners with BD to Provide COVID-19 Screen..
AQ
06/11BECTON DICKINSON ANDá : USA Swimming Partners with BD to Provide COVID-19 Screen..
PR
06/08INOGENá : Appoints Becton Dickinson Executive Stanislav Glezer as Chief Medical ..
MT
06/08BECTON DICKINSON ANDá : Reaches Injection Device Milestone in Support of Global ..
MT
06/08BECTON DICKINSON ANDá : BD Hits 2 Billion Injection Device Milestone in Support ..
PR
06/08BECTON, DICKINSON AND COMPANY : Ex-dividend day for
FA
06/02INSIDER TRENDS : Selling By Insiders Lingers at Becton Dickinson
MT
06/02BECTON DICKINSON ANDá : BD Advances Leadership in Cybersecurity Preparedness, Tr..
PR
06/01Abbott cuts 2021 profit forecast on lower COVID-19 testing demand
RE
05/26BECTON DICKINSON ANDá : BD to Present at Upcoming Investor Conferences in June
PR
More news
News in other languages on BECTON, DICKINSON AND COMPANY
04/07DGAP-HV : Fresenius Medical Care AG & Co. KGaA: -4-
2020VIRUS : la fabrication de seringues tourne aussi à plein régime
2020Mettler Toledo prépare la transition à sa direction générale
2020OLIVIER FILLIOL : CEO Olivier Filliol wird durch Patrick Kaltenbach abgelöst
2020TESLAá : Elon Musk a passé quatre tests Covid-19, dont deux positifs !
More news
Analyst Recommendations on BECTON, DICKINSON AND COMPANY
More recommendations
Chart BECTON, DICKINSON AND COMPANY
Duration : Period :
Becton, Dickinson and Company Technical Analysis Chart | BDX | US0758871091 | MarketScreener
Technical analysis trends BECTON, DICKINSON AND COMPANY
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Last Close Price 240,22 $
Average target price 279,00 $
Spread / Average Target 16,1%
EPS Revisions
Managers and Directors
NameTitle
Thomas E. Polen Chairman, President & Chief Executive Officer
Christopher R. Reidy Chief Financial & Administrative Officer, EVP
William R. Sigmund Chief Medical Officer & Executive Vice President
Jerry Flasz Chief Information Officer & EVP-Global Services
Elizabeth McCombs Chief Technology Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
BECTON, DICKINSON AND COMPANY-4.00%69 890
ABBOTT LABORATORIES1.34%197 156
MEDTRONIC PLC8.19%170 503
HOYA CORPORATION4.06%49 121
ALIGN TECHNOLOGY, INC.13.16%47 855
SARTORIUS STEDIM BIOTECH30.91%41 837